Zim Laboratories Limited
Zim Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ZIMLAB and BSE: 541400 (ISIN INE518E01015).
It has a market capitalisation of ₹739 crore, a last close of ₹138.17 on 2026-10-19, a one-year return of 101.9%.
Valuation: a price-to-earnings ratio of 200x, a price-to-book ratio of 2.50x, a dividend yield of 0.0%.
Profitability: return on equity of 2.1%, return on capital employed of 6.5%, an operating margin of 7.1%.
Growth: sales growth of -2.1% a year over three years, net profit growth of -37.9% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.42x, promoter holding of 30.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 739 |
| Last close | ₹138.17 |
| P/E (TTM) | 200x |
| P/B | 2.50x |
| Dividend yield | 0.0% |
| ROE (FY) | 2.1% |
| ROCE (FY) | 6.5% |
| Operating margin (TTM) | 7.1% |
| Sales growth, 3-year CAGR | -2.1% |
| Profit growth, 3-year CAGR | -37.9% |
| Debt / equity | 0.42x |
| Promoter holding | 30.3% |
| 1-year return | 101.9% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means